# Ruzaika Cader

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ruzaika-cader/

## Facts

| Field | Value |
| --- | --- |
| Citations | 13 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 2 |
| i10-index | 0 |
| Last Known Institution | University of Cambridge |
| OpenAlex ID | https://openalex.org/A5113323922 |
| Works | 3 |

## Researcher papers

- [A randomised, two-arm (1:1 ratio), double blind, placebo controlled phase III trial to assess the efficacy, safety, cost and cost-effectiveness of Rituximab in treating de novo or relapsing NS in patients with MCD/FSGS (TURING)](https://scholariq.org/papers/a-randomised-two-arm-1-1-ratio-double-blind-placebo-controlled-phase-iii-trial/)
- [Advances in primary glomerulonephritis](https://scholariq.org/papers/advances-in-primary-glomerulonephritis/)
- [Study Protocol: The Use of Rituximab in Nephrotic Glomerulonephritis (TURING)](https://scholariq.org/papers/study-protocol-the-use-of-rituximab-in-nephrotic-glomerulonephritis-turing/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)

## Researcher university

- [University of Cambridge](https://scholariq.org/institutions/university-of-cambridge/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.